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Timothy P. Carmody, Carol Duncan, Joel A. Simon, Sharon Solkowitz,
Joy Huggins, Sharon Lee, Kevin Delucchi
Received 16 February 2007; accepted 15 August 2007
The purpose of this study was to determine whether hypnosis would be more effective in helping smokers quit than
standard behavioral counseling when both interventions are combined with nicotine patches (NP). A total of 286
current smokers were enrolled in a randomized controlled smoking cessation trial at the San Francisco Veterans
Affairs Medical Center. Participants in both treatment conditions were seen for two 60-min sessions, and received
three follow-up phone calls and 2 months of NP. At 6 months, 29% of the hypnosis group reported 7-day point-
prevalence abstinence compared with 23% of the behavioral counseling group (relative risk [RR]51.27; 95%
confidence interval, CI 0.84–1.92). Based on biochemical or proxy confirmation, 26% of the participants in the
hypnosis group were abstinent at 6 months compared with 18% of the behavioral group (RR51.44; 95% CI 0.91–
2.30). At 12 months, the self-reported 7-day point-prevalence quit rate was 24% for the hypnosis group and 16%
for the behavioral group (RR51.47; 95% CI 0.90–2.40). Based on biochemical or proxy confirmation, 20% of the
participants in the hypnosis group were abstinent at 12 months compared with 14% of the behavioral group
(RR51.40; 95% CI 0.81–2.42). Among participants with a history of depression, hypnosis yielded significantly
higher validated point-prevalence quit rates at 6 and 12 months than standard treatment. It was concluded that
hypnosis combined with NP compares favorably with standard behavioral counseling in generating long-term quit
rates.
Introduction
Hypnosis has been used to help people to quit
smoking for many years (Green, 1996, 1999) and is
considered by some experts to be a form of
complementary and alternative medicine for smoking
cessation (Sood, Ebbert, Sood, & Stevens, 2006). In
recent studies (Green, 1999), hypnosis has been
shown to yield quit rates that are comparable with
those for multi-component treatments combining
counseling and nicotine replacement. However, the
evidence has not been considered strong enough to
include hypnosis as an evidence-based intervention in
the most recent smoking cessation clinical practice
guidelines (Abbott, Stead, White, Barnes, & Ernst,
2000; Fiore et al., 2000; Ranney, Melvin, Lux,
McClain, & Lohr, 2006). Well-controlled studies of
the efficacy of hypnosis for smoking cessation are
lacking (Lynn, Neufeld, Rhue, & Matorin, 1993).
Few of the studies investigating the efficacy of
hypnosis for smoking cessation have used biochem-
ical methods such as cotinine assays to verify
abstinence from smoking or have conducted follow-
up evaluations beyond 6 months (Holroyd, 1980). In
addition, many of the clinical reports of hypnosis for
smoking cessation have provided little detailed
information regarding the characteristics of partici-
pants (e.g., smoking history, hypnotizability), treat-
ment procedures, long-term outcome, information
on withdrawal symptoms, and reasons for relapse
(Green, 1999). Nevertheless, hypnosis continues to be
viewed with great interest among smokers consider-
ing treatment options for smoking cessation (Sood
et al., 2006).
Recent theoretical advances in the field of hypno-
sis involving the application of social cognitive
learning theory (Kirsch, Capafons, Cardena-
Buelna, & Amigo´, 1999) have generated renewed
interest in this treatment modality for smoking
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8 cessation, providing a theoretical foundation for
empirical research on the effectiveness of hypnosis
and mechanisms of change. For example, response
expectancies, motivational factors, and nonhypnotic
suggestibility are thought to be important mechan-
isms in determining the effects of both hypnotic and
nonhypnotic suggestions (Braffman & Kirsch, 1999;
Milling, Kirsch, Allen, & Reutenauer, 2005).
We undertook the present study to determine
whether a specific hypnosis intervention would prove
to be more effective in helping smokers quit
compared with standard behavioral counseling when
both treatments are combined with NP. We selected
a hypnosis treatment that was designed to promote
commitment to sustained abstinence and self-regula-
tory coping responses to enhance smoking cessation
and relapse prevention (Capafons, & Amigo´, 1995;
Lynn et al., 1993), incorporating suggestions and
guided imagery procedures developed by Spiegel
(1994), Lynn et al. (1993), Green (1996, 1999), and
Gorassini and Spanos (1986). If this hypnosis
intervention proved to be superior or even roughly
equivalent to behavioral counseling, it would offer
another option for smokers who want to quit.
Methods
Participants
Between September 2001, and December 2003, we
enrolled 176 men and 110 women at the San
Francisco Veterans Affairs Medical Center
(Figure 1). Participants were current smokers who
were interested in quitting and reported smoking at
least 10 cigarettes per day during the pre-enrollment
week. Patients who had a contraindication to
nicotine replacement (n59) were excluded. Local
institutional review board approval was obtained
and all participants provided written informed
consent. We assessed readiness to quit using the
Stages of Change model (Prochaska & DiClemente,
1983) and recruited participants who were in the
contemplation or action stage of quitting.
A total of 81 (22%) eligible smokers declined to
enroll. Sixteen (6%) of those randomized did not
attend the second session of treatment or receive the
nicotine patches (NP), yielding a baseline of 270
participants; 141 in the hypnosis arm and 129 in
behavioral counseling. Of those who did not attend
the second session, 12 were randomized to behavioral
Figure 1. Participant flow chart.
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8 counseling and 4 were randomized to hypnosis. Of
the 270 participants who attended both sessions and
received NP, 16 (6%) were lost to follow-up, 3 (1%)
withdrew, and 5 participants (2%) died. Analyses
that considered lost-to-follow-up participants as
smokers did not include the 5 participants who died.
Thus, 246 subjects (125 in the hypnosis arm and 121
in the behavioral arm) completed the final follow-up
assessment at 12 months and the data for 265
subjects (137 in the hypnosis arm and 128 in the
behavioral arm) were used in the analyses
that considered lost-to-follow-up participants as
smokers.
Interventions
We randomly assigned participants to the two study
arms. The two interventions were equivalent in terms
of the amount of contact time with the counselor.
Participants in both treatment arms were given a
two-month supply of NP with the initial dose (either
21 or 14 mg) based on the number of cigarettes
smoked per day before enrollment. Intervention
participants in both study arms received three
follow-up telephone counseling calls at weeks 3, 4,
and 6. The telephone intervention sessions, which
lasted about 20 min, continued the skills training
initiated during the initial counseling session.
Participants who had relapsed were encouraged to
set new quit dates.
Hypnosis intervention
The hypnosis intervention was administered by a
public health educator who received intensive train-
ing and ongoing supervision from the first author.
The hypnosis intervention was scripted and audio-
taped. Participants randomized to the hypnosis
treatment group participated in two 60-min face-to-
face sessions of hypnosis training and were provided
with an audiotape of this training to use daily at
home. The hypnosis intervention utilized suggestions
and guided imagery procedures developed by Spiegel
(1994), Lynn et al. (1993), Green (1996, 1999), and
Gorassini and Spanos (1986). Learning, practicing,
and employing hypnotic skills in resisting the urge to
smoke were core components of this intervention.
The goal of this treatment was for participants to
master hypnosis skills and to use these skills to
increase motivation and self-efficacy for resisting
temptations to smoke. Hypnosis was viewed as a set
of skills and ‘‘self-directed responses to suggestions’’
aimed at facilitating self-control over smoking
behavior and motivation for quitting and continued
abstinence from smoking. Participants were provided
with a menu of skills for coping with withdrawal
symptoms and the urge to smoke. Hypnotic
suggestions encouraged relaxation, commitment to
quitting, self-image as a nonsmoker, ability to resist
the urge to smoke, mood management, and devel-
opment of a healthy lifestyle. Suggestions involving
‘‘anchoring’’ gestures were included to help partici-
pants to generate adaptive coping responses to
sustain abstinence from smoking in ‘‘high-risk’’
situations. The hypnosis suggestions for both ses-
sions were provided on audiotape so that partici-
pants could practice this technique on their own. The
hypnotic suggestions and use of the training audio-
tape were reinforced during the three follow-up
phone calls.
Behavioral intervention
Smokers randomized to the evidence-based beha-
vioral intervention were counseled in two face-to-face
sessions, each lasting 60 min, and during three 20-
min follow-up phone calls at weeks 3, 4, and 6. In
these sessions, the dangers of smoking and the
benefits of quitting were reviewed, participants’
knowledge, beliefs, and potential barriers to smoking
cessation were assessed, and counter-arguments to
belief barriers were provided. Behavioral self-man-
agement techniques to counter relapse triggers were
also discussed and rehearsed. The behavioral inter-
vention was also administered by a public health
educator and was based on social learning theory
(Bandura, 1997) and the Stages of Change model
(Prochaska & DiClemente, 1983).
Data collection measures
History of alcohol/drug use and history of depression
were measured on single items on which participants
reported presence or absence of such a history. To
measure hypnotic depth, we asked the participants to
rate their experience of depth during both hypnosis
sessions on a scale from 1 (lowest level of depth) to
40+ (highest level of depth). To measure expectancy
of intervention helpfulness at baseline, participants
were asked to rate expected helpfulness of each
intervention on a 3-point scale from 1 (not helpful) to
3 (very helpful).
At the end of treatment, to assess use and
perceived helpfulness of various strategies included
in the hypnosis treatment, participants were asked
whether or not they used specific strategies and how
helpful they found the strategies they used on a 3-
point scale from 1 (not helpful) to 3 (very helpful).
These strategies included: repeating the key phrase,
using the ‘‘anchor’’ cue when feeling stressed,
imagining their special place, listening to the
hypnosis audiotape, practicing hypnosis regularly,
and hypnotizing themselves. To assess use and
helpfulness of quitting strategies taught in the
NICOTINE & TOBACCO RESEARCH 813
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8 behavioral treatment, participants were asked
whether or not they used specific quitting strategies
and how helpful they found the techniques they used
on a 3-point scale (15not helpful, 35very helpful).
These strategies included: reminding themselves of
their reasons for quitting, using oral substitutes,
planning responses for difficult situations, exercise,
using relaxation, changing their daily routine, and
rewarding themselves for not smoking.
Our measure of nicotine withdrawal symptoms
was a modified version of the Minnesota Nicotine
Withdrawal Scale (Hughes & Hatsukami, 1986) that
was used by Hurt et al. (1997) in their study of
bupropion for smoking cessation. It consisted of nine
items (craving, depressed mood, difficulty falling
asleep, awakening during the night, irritability,
anxiety, difficulty concentrating, restlessness, and
increased appetite). Participants responded to each
item, using a 5-point scale (05absent; 45severe). A
total nicotine withdrawal score was calculated with a
range of 0–36. This measure was administered at
weeks 2, 3, and 9.
We collected baseline data on age, race, sex,
marital status, presence of other smokers in the
household, level of education, history of drug or
alcohol abuse, and history of depression. Body mass
index (weight in kg divided by height in meters2) was
calculated using self-reported data. Medical pro-
blems were recorded based on participant interviews.
We obtained self-reported data on pre-enrollment
level of smoking, pack-years of smoking, and
number of prior quit attempts. Estimated level of
tobacco addiction was based on the Fagerstro¨m Test
of Nicotine Dependence (FTND; Fagerstro¨m,
Heatherton, & Kozlowski, 1992). A 20-item self-
efficacy questionnaire (Prochaska, Velicer,
DiClemente, & Fava, 1988) was administered at
baseline. We assessed depressive symptoms using the
Beck Depression Inventory (BDI; Beck, Steer, &
Brown, 1996). On the BDI measure, total scores
range from 0 to 63 and are divided into four levels of
depression (0–13 minimal, 14–19 mild, 20–28 mod-
erate, and 29–63 severe). At each follow-up phone
call, information was obtained regarding smoking
status, nicotine withdrawal symptoms, and use of
NP.
At the 6-month telephone follow-up, additional
data were obtained regarding quit attempts since
enrollment, current level of smoking, and date of the
last cigarette smoked. At the 12-month telephone
follow-up, we collected data on self-reported smok-
ing status, alcohol consumption, presence of smokers
in the household, quit attempts over the previous
6 months, date of last cigarette smoked, longest
period of tobacco abstinence, duration of use of
nicotine therapy, and use of other tobacco
products.
Smoking cessation and biochemical validation
We recorded self-reported point-prevalence tobacco
abstinence (defined as no smoking, not even a puff,
for 7 days) at 6 and 12 months. For participants who
reported they had quit smoking, we obtained saliva
samples for cotinine testing and used levels >15 ng/
ml as an indicator of current tobacco use. For self-
reported quitters with cotinine levels >15 ng/ml, we
ascertained by telephone interview whether they were
using nicotine replacement on the follow-up date.
There were four such participants at 6 months and
six participants at 12 months who were analyzed as
smokers. We considered participants who had
stopped smoking cigarettes, but were using other
tobacco products, as smokers. Saliva samples were
stored at 221uC until assayed for cotinine. For self-
reported quitters who provided no saliva specimen,
we accepted a statement by a spouse or significant
other regarding their smoking status. At 6 months,
there were 17 such participants (7 from the hypnosis
group and 10 from the behavioral group); and at
12 months, there were 11 (6 from the hypnosis group
and 5 from the behavioral group). Such proxy
reports have been shown to be reliable (Chen,
Rennie, & Dosman, 1995).
Statistical analysis
To compare the baseline variables, we used two-
sample t-tests and Wilcoxon rank-sum tests for
continuous variables and chi square tests for
categorical variables. To compare treatment out-
comes, we calculated the relative risk (RR) and 95%
confidence interval (CI) associated with randomiza-
tion to the hypnosis intervention using standard
formulae. We used multiple logistic regression
models that controlled for treatment assignment to
examine baseline variables as independent predictors
of quitting and calculated additional logistic regres-
sion models that included interactions between
treatment assignment and baseline variables.
Results
There were no significant differences in baseline
characteristics between the two treatment groups (all
p..05) (Table 1). Participants were predominantly
unmarried, white, and middle-aged. Smoking his-
tories were also similar in the two groups.
Participants were moderate to heavy smokers with
a mean of 29 pack-years of smoking, and were
smoking just over one pack of cigarettes daily at the
time of enrollment. History of depression was highly
prevalent in both groups (33% in the hypnosis
group and 40% in the behavioral group). Mean
expected helpfulness ratings were similar for the two
814 HYPNOSIS FOR SMOKING CESSATION
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intervention groups: 4.20 (SD50.76) for the hypnosis
group and 4.12 (SD50.85) for the behavioral group
(p5.329).
A comparison of the study medication log kept
during the intervention indicated that the two
treatment groups did not differ in their use of NP.
The mean number of NPs used by participants was
33 (SE51.9) in the hypnosis group and 36 (SE51.8)
in the behavioral group (p5.354). In addition,
severity of nicotine withdrawal symptoms was
compared for the two treatment groups at weeks 2,
3, and 9. Severity of nicotine withdrawal symptoms
was significantly higher for the behavioral group
(M513.5, SD57.3) than for the hypnosis group
(M510.9, SD55.7) at week 2 (p5.03), but was not
significantly different between the two treatment
conditions at weeks 3 and 9.
Using follow-up data from those participants who
were available at the 6-month assessment, the 7-day
point-prevalence quit rate, based on self-report alone
and including dropouts as smokers, was 29% (40/
140) for the hypnosis group and 23% (29/129) for the
behavioral counseling group (RR51.27; 95% CI
0.84–1.92, p5.27). Based on biochemical or proxy
confirmation, the point-prevalence quit rate was 26%
(36/140) for the hypnosis group versus 18% (23/129)
for the behavioral group (RR51.44; 95% CI 0.91–
2.30, p5.14). At 12 months, the self-reported point-
prevalence quit rate, including dropouts as smokers,
was 24% (33/137) for the hypnosis group and 16%
(21/128) for the behavioral group (RR51.47; 95% CI
0.90–2.40, p5.13). Based on biochemical or proxy
confirmation, the point-prevalence quit rate was 20%
(27/137) for the hypnosis group and 14% (18/128) for
the behavioral group at 12 months (RR51.40; 95%
CI 0.81–2.42, p5.25). Results were similar when
participants who were lost to follow-up were
excluded from the analyses (Table 2). Rates of self-
reported quitting were higher than those confirmed
biochemically. However, the magnitude of the
benefit associated with both interventions at 1 year
was similar in all the statistical models.
Because other variables were associated with
point-prevalence quitting, we examined additional
logistic regression models for both measures of
smoking status (self-reported and validated absti-
nence) at 6 and 12 months. The variables associated
with point-prevalence quitting included gender,
ethnicity, history of alcohol abuse, history of
depression, number of other smokers in the house-
hold, expected helpfulness of treatment, nicotine
dependence measured on the FTND, and number of
quit strategies. In addition, we examined the inter-
actions between treatment assignment and gender,
ethnicity, alcohol history, depression history, and
number of quit strategies. Only the logistic regres-
sion models predicting self-reported and validated
Table 1. Baseline characteristics of the study participants
(N5286).
Characteristic*
Hypnosis
group
(n5145)
Behavioral
group
(n5141) p value{
Age (years) 45¡12 45¡13 .90
White (%) 101 (70) 96 (68) .80
Women (%) 61 (42) 49 (35) .23
Married (%) 37 (26) 34 (24) .70
Veteran (%) 47 (32) 54 (38) .32
Level of education (years){ 15¡2 14¡2 .25
Current tobacco use
(cigarettes/day){
20¡8 20¡10 .63
Smoking (pack-years) 29¡21 30¡24 .66
Beck Depression Inventory
Score{
11¡9 10¡9 .39
Fagerstro¨m Score{ 5¡2 5¡2 .75
Expected helpfulness
(scale 1–5)
4¡0.8 4¡0.9 .42
Coronary disease (%) 8 (6) 10 (7) .63
Vascular disease (%) 10 (7) 6 (4) .40
COPD (%) 15 (10) 18 (13) .58
History of tobacco-related
cancer (%)
3 (2) 2 (1) 1.00
Diabetes mellitus (%) 9 (6) 9 (7) 1.00
Hypertension (%) 29 (20) 25 (18) .65
Alcohol abuse (%) 30 (21) 28 (20) 1.00
Drug abuse (%) 22 (15) 25 (18) .63
History of depression (%) 47 (33) 55 (40) .27
*Values are means¡SD. Other values denote the number and
percentage of subjects. {N5286 for level of education achieved;
N5285 for Beck Depression Inventory; N5285 for Fagerstro¨m
Score. {Current tobacco use was defined as the average number
of cigarettes smoked per day.
Table 2. Smoking cessation rates and the relative risk of quitting.
Hypnosis group,
no. (%) quit
Behavioral group,
no. (%) quit
Relative risk
(95% CI) p value
Self-report at 1 week 77/141 (55) 73/129 (56) 0.97 (0.79–1.20) .81
Self-report at 2 weeks 64/141 (45) 68/129 (53) 0.87 (0.68–1.11) .28
Self-report at 8 weeks 54/141 (38) 47/129 (36) 1.06 (0.78–1.44) .80
Self-report at 6 months 40/140 (29) 29/129 (23) 1.27 (0.84–1.92) .27
Validated* at 6 months 36/140 (26) 23/129 (18) 1.44 (0.91–2.30) .14
Validated{ at 6 months 36/133 (27) 23/124 (19) 1.44 (0.90–2.28) .14
Self-report at 12 months 33/137 (24) 21/128 (16) 1.47 (0.90–2.40) .13
Validated* at 12 months 27/137 (20) 18/128 (14) 1.40 (0.81–2.42) .25
Validated{ at 12 months 27/125 (22) 18/121 (15) 1.45 (0.85–2.50) .19
CI, confidence interval. *Validated by saliva cotinine level or spousal proxy. Participants lost to follow-up were considered smokers.
{Validated by saliva cotinine level or spousal proxy. Participants lost to follow-up were excluded.
NICOTINE & TOBACCO RESEARCH 815
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8 quitting at 6 months were statistically significant
(Wald x2526.58, p,.02; Wald x2526.75, p,.02,
respectively). Of the possible interactions examined,
only the interaction of treatment assignment with
history of depression was significant in predicting
validated quitting at 6 months (p,.01). As shown in
Figure 2, at 6 months, in the hypnosis condition,
participants with a history of depression had greater
validated quit rates than those without a history of
depression while the relationship was reversed in the
behavioral condition.
For participants assigned to the hypnosis group,
we examined the relationship between perceived
depth of hypnosis and outcome. The mean perceived
depth averaged across the two hypnosis intervention
sessions was not significantly related to validated
quitting at 12 months (M514.7, SD58.7 for
validated quitters; M513.4, SD58.4 for smokers,
p5.50).
We also investigated the relationship between use
of specific quitting strategies and validated outcome
for both groups combined with dropouts counted as
smokers. Abstinent participants reported using an
average of 4 quit strategies (SD52.8) compared with
a mean of 2.8 (SD52.8) for smokers (p,.001). As
shown in Figure 3, the validated point-prevalence
quit rates at 6 and 12 months were significantly
higher for participants who used more quitting
strategies (6 months: Jonckheere–Terpstra Z-
test53.36, p,.001; 12 months: Jonckheere–Terpstra
Z-test53.20, p,.002). In addition, among partici-
pants in the hypnosis group, the regular practice of
hypnosis (i.e., listening to the audiotapes at least
once a week) was significantly associated with
validated quitting at 12 months (r5.33, p,.01).
Furthermore, validated quitting at 12 months was
positively associated with the rated helpfulness of
using a key phrase (r5.35, p,.01) and using their
‘‘anchor’’ when feeling stressed (r5.31, p,.05).
Discussion
We found that hypnosis combined with NP yielded
long-term smoking cessation rates that were slightly
higher than those for behavioral counseling and NP.
In measuring primary outcomes, we employed
several definitions of smoking cessation. Our cessa-
tion findings based on self-report as well as those
validated by biochemical analysis or proxy report
were comparable. In logistic models that controlled
for other predictors of cessation, treatment assign-
ment was not associated with a statistically signifi-
cant difference in the probability of cessation.
Interestingly, in the sub-group of smokers with a
history of depression, the validated point-prevalence
quit rates at 6 and 12 months were higher for those
who participated in the hypnosis intervention.
Furthermore, the number of dropouts from treat-
ment was higher for the behavioral group than for
the hypnosis intervention. This result is consistent
with the observation that people commonly view
hypnosis as a popular and viable method for
achieving smoking cessation. Taken together, these
results support the efficacy of hypnosis as a smoking
cessation treatment, particularly among smokers
with a history of depression.
In recent studies, hypnosis has been shown to
generate quit rates that are comparable with those
for standard treatments combining counseling and
nicotine replacement (Green, 1999). In one recent
review (Green & Lynn, 2000), it was concluded that
hypnosis yielded higher quit rates than wait-list
control groups, and was generally comparable with
other interventions that did not involve hypnosis.
The design and assessment methodology of this
study did not allow us to determine how hypnosis
achieved its effect. Number of quitting strategies was
found to be predictive of successful outcome, but the
Figure 3. Validated point-prevalence quit rates by
number of quit strategies used across both treatments.
Figure 2. Validated point-prevalence quit rates by
treatment assignment and history of depression.
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8 two treatment groups did not differ on this variable.
Among participants in the hypnosis group, perceived
depth of hypnotic response was not found to be
predictive of successful outcome. However, those
participants who reported practicing the hypnosis
technique regularly (i.e., at least once a week) were
found to have higher quit rates. In addition,
participants in the hypnosis treatment condition
reported significantly less severe nicotine withdrawal
symptoms than those in the behavioral group, but
only at week 2. Future studies might investigate the
impact of hypnosis on withdrawal more closely.
Mechanisms underlying the utility of hypnosis for
smoking cessation are unknown, but may involve
several factors, including expectation and placebo
factors, enhancement of responsiveness to sugges-
tions, alteration of unconscious impulses that serve
to maintain smoking, and enhancement of ability to
focus attention on treatment strategies (Green, 1999;
Milling et al., 2005).
According to the cognitive behavioral model of
hypnosis, hypnotic treatments may affect behavior
change by means of cognitive, behavioral, and
educational aspects of the suggestions given by the
therapist (Schwartz, 1992). Reinforcement of moti-
vational and self-regulation messages may facilitate
initial cessation, resistance to the temptation to
smoke, and maintenance of abstinence (Lynn et al.,
1993). Alternatively, response expectancy has been
posited as the causal mechanism in both hypnosis
and placebo interventions (Kirsch, 1997; Milling,
Reardon, & Carosella, 2006). According to this
perspective, hypnosis is thought to achieve its effect
by changing the person’s expectations for nonvoli-
tional reactions to hypnotic suggestions. Some
experts view hypnosis as a nondeceptive placebo,
creating a cognitive set or anticipation of a
nonvolitional response (Kirsch, 1999). Whether the
effects of hypnosis are partially or fully related to
the role of response expectancy is not known. In the
present study, the two treatment groups did not
differ in their baseline ratings of the expected
helpfulness of the intervention to which they were
assigned.
According to self-regulation theory, hypnosis is
considered a state of receptive, attentive concentra-
tion that is designed to facilitate responsiveness to
suggestions regarding behavior change (Capafons &
Amigo´, 1995). That is, the individual learns, prac-
tices, and applies hypnotic suggestion as a coping
strategy on a daily basis to initiate and maintain a
desired behavior change. Furthermore, the hypnotic
suggestions used in the present study included visual
imagery aimed at increasing motivation and self-
efficacy for quitting and remaining abstinent from
smoking. For most people, adding a hypnotic
induction to imaginative suggestions yields an
increase in responding (Braffman & Kirsch, 1999;
Milling et al., 2005).
In interpreting these findings, study limitations
need to be considered. For instance, since hypnosis
was combined with NP, we are unable to draw any
conclusions regarding the efficacy of hypnosis as a
single treatment modality. Another limitation was
the fact that the research assistants conducting the
follow-up assessment phone calls were not blind to
the treatment conditions of the participants. In
addition, although we did have a comparison group,
we did not include a placebo control and are
consequently unable to comment on how the
hypnosis or behavioral counseling groups might
have compared with a placebo control. We also do
not know whether a larger study might have
demonstrated statistically significant differences
between the study arms, especially since the quit
rates in the hypnosis arm were somewhat higher than
those in the behavioral group. Furthermore, it would
be premature to draw any conclusions regarding the
use of hypnosis for smokers with history of depres-
sion. Our measure of history of depression was not
based on a diagnostic interview and did not
differentiate between major, single-episode, recur-
rent, or other forms of depression. Finally, we are
unable to determine mechanisms by which treatment
success was achieved in the hypnosis treatment
group.
It might be argued that we were unable to
determine the degree to which the NP in both
treatment conditions was responsible for the out-
comes achieved. However, recent meta-analyses that
form the empirical basis for current practice guide-
lines (Fiore et al., 2000; Ranney et al., 2006) clearly
indicate not only that NP is an effective treatment for
nicotine dependence, but also that brief counseling
added to NP significantly increases validated long-
term quit rates. In the present study, the two
treatment groups did not differ in their use of NP.
Thus, the quit rates generated by the hypnosis
treatment group in the present study, which com-
pared favorably with those achieved by the beha-
vioral counseling condition, provide support for
hypnosis as an additional smoking cessation inter-
vention.
In conclusion, the validated point-prevalence quit
rates in the hypnosis treatment arm exceeded those of
the behavioral counseling arm at both 6 and 12
months of follow-up. Among participants with a
history of depression, hypnosis yielded a significantly
higher point-prevalence quit rate at 6 and 12 months
than the behavioral treatment. Among participants
randomized to the behavioral group, the quit rate for
participants with a history of depression was
considerably lower at 6 months than the quit rate
for participants without a history of depression, but
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8 slightly higher at 12 months. Further research is
needed to replicate and explore the meaning of these
post-hoc findings. We believe that the results of our
study support the use of hypnosis as an evidence-
based intervention for smoking cessation, at least
when combined with NP.
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